Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NREP antisense RNA 1 (NREP-AS1) is a human long non-coding RNA classified as an antisense transcript located on chromosome 5, on the plus strand, with multiple transcript isoforms described. It does not encode a protein. To date, there are no publications or experimental data describing its function, disease relevance, or biological significance, and it is not conserved in model organisms. No clinical or preclinical evidence exists linking NREP-AS1 to disease or drug response, and it is not established as a therapeutic or biomarker target.
Not applicable, as there are no therapeutic interventions or drugs reported to act on this lncRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NREP antisense RNA 1 (NREP-AS1).